APOE and triple-A syndrome: In ApoE−/− mice, in the third part of in vivo experimentations (Figure S1), the incidence of AAA was 80%, 84% and 48% in the no treatment, sh‐NC and sh‐NONO groups, respectively, compared with that in the control group which had no AAA (Figure 2A‐D and Figure S3).